The disruption in the RAC1-PAK1 in non-responders represents only a fraction of the findings in this manuscript—the integration of multiple molecular and computational techniques in a biologically contextualized manner represents an innovative step forward into the realm of precision medicine-based diagnostic and prognostic tools in IBD and beyond. This evidence concerns the gene RAC1 and inflammatory bowel disease.